Infectious Disease & VaccinesJan 10, 2022|10 min readBy Stephanie DeMarco, PhDAnimal microbiomes hold the key to new antifungalsFrom sea squirts to ants to opossums on the side of the road, the bacteria that live in animal microbiomes are a surprising source of new antifungals.
UnknownFeb 23, 2021|3 min readBy DDNews StaffA commercialization agreement for ibrexafungerpIbrexafungerp on track for FDA approval in June for vaginal yeast infections
Internal MedicineJan 26, 2021|4 min readBy Mel J. YeatesIbrexafungerp advances the fight against fungusIV compound enters Phase 1, following FDA Priority Review and Fast Track designations for oral formulation